Assessment of Risk Factors for Chronic Kidney Disease in Djamaa (El Oued, Algeria) Population
,
Abstract
Purpose: This study was conducted aiming at evaluating some risk factors in patients with Chronic Kidney Disease (CKD) in Djamaa (El Oued, Algeria) region.
Materials and Methods: Our study is based on 77 voluntary individuals divided into healthy man and women reserved as a control with average age of 46.61± 2.84 years old and CKD patients with average age of 46.03± 2.95 years old; their origin covers the whole Djamaa (El Oued, Algeria) region and they were selected from the dialysis service of SAAD DEHLEB hospital Djamaa (El Oued Algeria). Risk of certain socio-clinical factors has been estimated by the determination of the value of Odd Ratio (OR).
Results: Our study reports show a strong association between clinical factors such as Diabetes, urinary problems and Arterial hyper pressure (OR= 5.135, 6.60 and 78.276; P ≤0.05) with chronic kidney disease, respectively, but in this study we show that the Renal herbal medicine and History of kidney disease are the most dangerous risk factors, (OR = 20.00, OR =25,45 ; p≤0.001), respectively, for spices and Amount of water (OR ranging from 0.232 to 0.352; P ≤0.032) are important protective factors against this disease.
Conclusion: Lifestyle is a contributing factor in CKD attainment in the region of Djamaa (El Oued, Algeria), which requires high sensitivity to modify these behaviors for limited progression of the disease in this region.
1- E. Fung, T. M. Kurella. Epidemiology and Public Health Concerns of CKD in Older Adults. Adv Chronic Kidney Dis. Vol. 23(1), pp. 8-11, 2016.
2- H. Salah. An Overview of Renal Replacement Therapy in Algeria. Saudi J Kidney Dis Transp. Vol. 5 pp. 190-2, 1994.
3- V. Jha, G. Garcia-Garcia,k, Iseki, Li Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y., Yang, C. W. Chronic kidney disease: global dimension and perspectives. Lancet, Vol. 382 (9888), pp. 260-72, 2013.
4- L. Zhang, D. Rothenbacher. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health, Vol. 8, pp. 117 - ??, 2008.
5- R. J. Glassock, C. Winearls. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc. Vol. 120, pp. 419-28, 2009.
6- P. Delanaye, R.J. Glassock, H. Pottel, A.D. Rule. An Age-Calibrated Definition of Chronic Kidney Disease: Rationale and Benefits. Clin Biochem Rev. Vol. 37(1), pp. 17-26, 2016.
7- J. Ahern, M.R. Jones, E. Bakshis, S. Galea. Revisiting rose: comparing the benefits and costs of population-wide and targeted interventions. Milbank Q. Vol. 86, no. 4, pp. 581-600, 2008.
8- S. Hwang, J. Tsai, H. Chen. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan; Nephrology, Vol. 15, pp. 3–9, 2010.
9- R. Kazanciog. Risk factors for chronic kidney disease: an update; Division of Nephrology, Faculty of Medicine, BezmialemVakif University, Istanbul, Turkey. Kidney International Supplements, Vol. 3, pp. 368–371, 2013.
10- C.A. Robert. The epidemiology of chronic kidney disease. Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia. Kidney International, Vol. 67(94), pp. S14–S18, 2005.
11- A.L. Valerie, M.B. Barry. The Clinical Importance of Nephron Mass; Journal of the American Society of Nephrology. 2010. doi: 10.1681/ASN.2009121248.
12- Derouiche S, Atoussi N, Guediri S. The Study of Socioeconomic and Clinic Risk Factors of Breast Cancer in Algerian Women Population. Front. Biomed. Tech. Vol. 5(3-4), pp. 51-57, 2018.
13- B.S. Neil, E.F. Charles, H.W. Dallas, M. Donald Blaufox, S. David, G. L. Herbert, A. Kenneth. Prognostic Value of Serum Creatinine and Effect of Treatment of Hypertension on Renal Function. Schneider on behalf of the Hypertension Detection and Follow-up Program Cooperative Group. Supplement I Hypertension, Vol. 13(5), pp. 80-93, 1989.
14- S. Karie, F. Gandjbakhch, N. Janus, V. Launay-Vacher, S. Rozenberg, C.U. Mai Ba, P. Bourgeois. Deray G. Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study. Rheumatology, Vol. 47, pp. 350–354, 2008.
15- H. Chiu, H. Huang, C. Li, H. Chen, C. Ye, S. Chiu, W. Lin, Y. Cheng, T. Tsai, S. Ho. Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications – A National Population-Based Cohort Study. Emmanuel A Burdmann, University of Sao Paulo Medical School, BRAZIL; PLoS ONE, Vol. 10(9), e0136508. 2015. doi:10.1371/journal.pone.0136508.
16- W.K. Hyun, C. Lee, H. Cha. J. Choe, E. Park, J. Kim. Effect of anti-tumor necrosis factor alpha treatment of rheumatoid arthritis and chronic kidney disease. Rheumatol Int. 2014. DOI 10.1007/s00296-014-3146-4.
17- J.H. LaTonya, S.C. Cynthia, E.G. Sherine, T.M James, L.M. Eric. Development of Reduced Kidney Function in Rheumatoid Arthritis. Am J Kidney Dis. Vol. 63(2), pp. 206-213, 2014.
18- K. Holmgren, B.G. Danielson, B. Fellstrom. Infection-induced urinary calculi and renal failure; From the Departments of 'Urology and Internal Medicine, University Hospital, S-7.5185 Uppsala. Sweden. Scand J UrolNephrol, Vol. 21, pp. 219-223, 1987.
19- T. Eleftheria, B. Vagia, S. Areti, S. Kostas, R. Michael, Z. Zacharias. Causes and complications of chronic kidney disease in patients on dialysis .Department of Nursing, Technological Educational Institute of Athens; Health Science Journal, Vol. 8(3), pp. 343-349, 2014.
20- M.A. David, A. F. Morey, L.G. Gomella, J.P. Stein. Urinary tract infection: definitions, incidence, and investigations chp 05: Infections and inflammatory conditions. Oxford American Handbook of Urology. Vol. 691, pp. 133-154, 2011.
21- Kidney Foundation of Canada. Living with reduced kidney function; 5th Edition, 2015
22- G.T. Obrador, U.T. Schultheiss, M. Kretzler. Genetic and environmental risk factors for chronic kidney disease. Kidney Int Suppl. Vol. 7, no. 2, pp.88-106, 2017.
23- P. Kincaid-Smith. The Treatment of Glomerulonephritis; From the Department of Medicine, University of Melbourne and Royal Melbourne Hospital, Victoria. AustN. Z. J. Med. Vol. 10(3), pp.340-345, 1980.
24- L.J. Colin, A.E. Allison. Tubule interstitial nephritis. Pediatr Nephrol. Vol. 6, pp. 572-586, 1992.
25- Y.J. Choi, S. Chakraborty, V. Nguyen, C. Nguyen, B.K. Kim, S.I. Shim, W.N. Suki, L.D. Truong. Peritubular capillary loss is associated with chronic tubule interstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum Pathol. Vol. 31(12), pp. 1491-1497, 2000.
26- A. Meyrier. Nephrosclerosis: update on a centenarian ; Université Paris-Descartes, Paris, France and Département de Néphrologie, Hôpital Georges Pompidou (AP-HP), Paris, France.Nephrol Dial Transplant, Vol. 30, pp. 1833–1841, 2015.
27- C.I. Bagnis, G. Deray, A. Baumelou, L.Q. Moglie, J.L. Vanherweghem. Herbs and the Kidney. American Journal of Kidney Diseases, Vol. 44(1), pp. 1-11, 2004.
28- J. Vanherweghem, Misuse of Herbal Remedies: The Case of an Outbreak of Terminal Renal Failure in Belgium (Chinese Herbs Nephropathy). The Journal of Alternative and Complementary Medicine, Vol. 4(1), pp. 9-13, 1998.
29- S. Derouiche, K. Zeghib. Evaluation of the Chelating Efficacy of Aquilaria malaccensis and Aristolochia longa Against Biochemical Alterations Induced by Lead Bioaccumulation in Rats. Pharmaceutical and Biosciences Journal, Vol. 7(2), pp. 11-15, 2019.
30- M.A. Perazella. Renal Vulnerability to Drug Toxicity. Clin J Am Soc Nephrol. Vol. 4, pp. 1275–1283, 2009.
31- R.L. Luciano, M.A. Perazella. Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment. Drug Saf, Vol. 38(1), pp. 55-64, 2015.
32- S.N. Fazel, A.H. Moghaddam, S. Eslami, S.M. Nabavi. Protective Effects of Curcumin against Sodium Fluoride-Induced Toxicity in Rat kidney. Biological Trace Element Research, Vol. 145(3), pp. 369-374, 2012.
33- O. Bayrak, U. Ebru, B. Reyhan, T. Faruk, A.F. Atmaca, S. Sahin, E.Y. Mehmet, A. Kaya E. Cimentepe, A. Akcay. Curcumin protects against ischemia/reperfusion injury in rat kidneys. World J Urol. Vol. 26, pp. 285–291, 2008.
34- K. Anurag, P. Sangeeta, S. Sameer, T. Naveen, C. Kanwaljit. Effect of Curcumin on Inflammation and Oxidative Stress in Cisplatin-Induced Experimental Nephrotoxicity. Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC Centre for Advanced Studies, Panjab University, Chandigarh-160014, India J. Agric. Food Chem. Vol. 55, pp. 10150–10155, 2007.
35- L.C. Tapsell, I. Hemphill, L. Cobiac, D.R. Sullivan, M. Fenech. Health benefits of herbs and spices: the past, the present, the future. The Medical Journal of Australia, Vol. 185(4), pp. S4-24, 2006.
2- H. Salah. An Overview of Renal Replacement Therapy in Algeria. Saudi J Kidney Dis Transp. Vol. 5 pp. 190-2, 1994.
3- V. Jha, G. Garcia-Garcia,k, Iseki, Li Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y., Yang, C. W. Chronic kidney disease: global dimension and perspectives. Lancet, Vol. 382 (9888), pp. 260-72, 2013.
4- L. Zhang, D. Rothenbacher. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health, Vol. 8, pp. 117 - ??, 2008.
5- R. J. Glassock, C. Winearls. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc. Vol. 120, pp. 419-28, 2009.
6- P. Delanaye, R.J. Glassock, H. Pottel, A.D. Rule. An Age-Calibrated Definition of Chronic Kidney Disease: Rationale and Benefits. Clin Biochem Rev. Vol. 37(1), pp. 17-26, 2016.
7- J. Ahern, M.R. Jones, E. Bakshis, S. Galea. Revisiting rose: comparing the benefits and costs of population-wide and targeted interventions. Milbank Q. Vol. 86, no. 4, pp. 581-600, 2008.
8- S. Hwang, J. Tsai, H. Chen. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan; Nephrology, Vol. 15, pp. 3–9, 2010.
9- R. Kazanciog. Risk factors for chronic kidney disease: an update; Division of Nephrology, Faculty of Medicine, BezmialemVakif University, Istanbul, Turkey. Kidney International Supplements, Vol. 3, pp. 368–371, 2013.
10- C.A. Robert. The epidemiology of chronic kidney disease. Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia. Kidney International, Vol. 67(94), pp. S14–S18, 2005.
11- A.L. Valerie, M.B. Barry. The Clinical Importance of Nephron Mass; Journal of the American Society of Nephrology. 2010. doi: 10.1681/ASN.2009121248.
12- Derouiche S, Atoussi N, Guediri S. The Study of Socioeconomic and Clinic Risk Factors of Breast Cancer in Algerian Women Population. Front. Biomed. Tech. Vol. 5(3-4), pp. 51-57, 2018.
13- B.S. Neil, E.F. Charles, H.W. Dallas, M. Donald Blaufox, S. David, G. L. Herbert, A. Kenneth. Prognostic Value of Serum Creatinine and Effect of Treatment of Hypertension on Renal Function. Schneider on behalf of the Hypertension Detection and Follow-up Program Cooperative Group. Supplement I Hypertension, Vol. 13(5), pp. 80-93, 1989.
14- S. Karie, F. Gandjbakhch, N. Janus, V. Launay-Vacher, S. Rozenberg, C.U. Mai Ba, P. Bourgeois. Deray G. Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study. Rheumatology, Vol. 47, pp. 350–354, 2008.
15- H. Chiu, H. Huang, C. Li, H. Chen, C. Ye, S. Chiu, W. Lin, Y. Cheng, T. Tsai, S. Ho. Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications – A National Population-Based Cohort Study. Emmanuel A Burdmann, University of Sao Paulo Medical School, BRAZIL; PLoS ONE, Vol. 10(9), e0136508. 2015. doi:10.1371/journal.pone.0136508.
16- W.K. Hyun, C. Lee, H. Cha. J. Choe, E. Park, J. Kim. Effect of anti-tumor necrosis factor alpha treatment of rheumatoid arthritis and chronic kidney disease. Rheumatol Int. 2014. DOI 10.1007/s00296-014-3146-4.
17- J.H. LaTonya, S.C. Cynthia, E.G. Sherine, T.M James, L.M. Eric. Development of Reduced Kidney Function in Rheumatoid Arthritis. Am J Kidney Dis. Vol. 63(2), pp. 206-213, 2014.
18- K. Holmgren, B.G. Danielson, B. Fellstrom. Infection-induced urinary calculi and renal failure; From the Departments of 'Urology and Internal Medicine, University Hospital, S-7.5185 Uppsala. Sweden. Scand J UrolNephrol, Vol. 21, pp. 219-223, 1987.
19- T. Eleftheria, B. Vagia, S. Areti, S. Kostas, R. Michael, Z. Zacharias. Causes and complications of chronic kidney disease in patients on dialysis .Department of Nursing, Technological Educational Institute of Athens; Health Science Journal, Vol. 8(3), pp. 343-349, 2014.
20- M.A. David, A. F. Morey, L.G. Gomella, J.P. Stein. Urinary tract infection: definitions, incidence, and investigations chp 05: Infections and inflammatory conditions. Oxford American Handbook of Urology. Vol. 691, pp. 133-154, 2011.
21- Kidney Foundation of Canada. Living with reduced kidney function; 5th Edition, 2015
22- G.T. Obrador, U.T. Schultheiss, M. Kretzler. Genetic and environmental risk factors for chronic kidney disease. Kidney Int Suppl. Vol. 7, no. 2, pp.88-106, 2017.
23- P. Kincaid-Smith. The Treatment of Glomerulonephritis; From the Department of Medicine, University of Melbourne and Royal Melbourne Hospital, Victoria. AustN. Z. J. Med. Vol. 10(3), pp.340-345, 1980.
24- L.J. Colin, A.E. Allison. Tubule interstitial nephritis. Pediatr Nephrol. Vol. 6, pp. 572-586, 1992.
25- Y.J. Choi, S. Chakraborty, V. Nguyen, C. Nguyen, B.K. Kim, S.I. Shim, W.N. Suki, L.D. Truong. Peritubular capillary loss is associated with chronic tubule interstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum Pathol. Vol. 31(12), pp. 1491-1497, 2000.
26- A. Meyrier. Nephrosclerosis: update on a centenarian ; Université Paris-Descartes, Paris, France and Département de Néphrologie, Hôpital Georges Pompidou (AP-HP), Paris, France.Nephrol Dial Transplant, Vol. 30, pp. 1833–1841, 2015.
27- C.I. Bagnis, G. Deray, A. Baumelou, L.Q. Moglie, J.L. Vanherweghem. Herbs and the Kidney. American Journal of Kidney Diseases, Vol. 44(1), pp. 1-11, 2004.
28- J. Vanherweghem, Misuse of Herbal Remedies: The Case of an Outbreak of Terminal Renal Failure in Belgium (Chinese Herbs Nephropathy). The Journal of Alternative and Complementary Medicine, Vol. 4(1), pp. 9-13, 1998.
29- S. Derouiche, K. Zeghib. Evaluation of the Chelating Efficacy of Aquilaria malaccensis and Aristolochia longa Against Biochemical Alterations Induced by Lead Bioaccumulation in Rats. Pharmaceutical and Biosciences Journal, Vol. 7(2), pp. 11-15, 2019.
30- M.A. Perazella. Renal Vulnerability to Drug Toxicity. Clin J Am Soc Nephrol. Vol. 4, pp. 1275–1283, 2009.
31- R.L. Luciano, M.A. Perazella. Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment. Drug Saf, Vol. 38(1), pp. 55-64, 2015.
32- S.N. Fazel, A.H. Moghaddam, S. Eslami, S.M. Nabavi. Protective Effects of Curcumin against Sodium Fluoride-Induced Toxicity in Rat kidney. Biological Trace Element Research, Vol. 145(3), pp. 369-374, 2012.
33- O. Bayrak, U. Ebru, B. Reyhan, T. Faruk, A.F. Atmaca, S. Sahin, E.Y. Mehmet, A. Kaya E. Cimentepe, A. Akcay. Curcumin protects against ischemia/reperfusion injury in rat kidneys. World J Urol. Vol. 26, pp. 285–291, 2008.
34- K. Anurag, P. Sangeeta, S. Sameer, T. Naveen, C. Kanwaljit. Effect of Curcumin on Inflammation and Oxidative Stress in Cisplatin-Induced Experimental Nephrotoxicity. Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC Centre for Advanced Studies, Panjab University, Chandigarh-160014, India J. Agric. Food Chem. Vol. 55, pp. 10150–10155, 2007.
35- L.C. Tapsell, I. Hemphill, L. Cobiac, D.R. Sullivan, M. Fenech. Health benefits of herbs and spices: the past, the present, the future. The Medical Journal of Australia, Vol. 185(4), pp. S4-24, 2006.
| Files | ||
| Issue | Vol 7 No 1 (2020) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/fbt.v7i1.2721 | |
| Keywords | ||
| Chronic Kidney Disease Risk Factors Protective Factors Djamaa | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Derouiche S, Cheradid T, Guessoum M. Assessment of Risk Factors for Chronic Kidney Disease in Djamaa (El Oued, Algeria) Population. Frontiers Biomed Technol. 2020;7(1):14-21.
